fig1

Figure 1. Clinical laboratory and cardiac parameters during hospitalization and follow-up. The figure is organized into three rows, displaying 12 panels in total. (A) Hematological and Inflammatory Markers; (B) Myocardial Injury and Hepatic Enzymes; (C) Cardiac Function and Metabolic Markers. In (C) (IL-6), the asterisks at days 5 and 8 indicate that the IL-6 concentration was below the lower limit of detection (i.e., not detectable), reflecting the rapid resolution of the systemic inflammatory response following immunomodulatory therapy. WBC: White blood cell; IL-6: interleukin-6; PLT: platelet; hs-TnI: high-sensitivity troponin I; CK: creatine kinase; CK-MB: creatine kinase-MB isoenzyme; AST: aspartate aminotransferase; LDH: lactate dehydrogenase; NT-proBNP: N-terminal pro-B-type natriuretic peptide; LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diameter.